A portfolio of high-quality healthcare real estate assets, which are geographically dispersed throughout Australia and underpinned by high-calibre operators, has been brought to market, providing a rare opportunity to invest in turnkey properties.
The $140million nine-asset healthcare portfolio is jointly marketed by Cushman & Wakefield and JLL.
The properties include five QLD assets, two VIC assets, a NSW asset and a WA asset. The properties are divested by the seven-year established, unlisted closed-end fund, Centuria Healthcare Direct Medical Fund No. 1.
The healthcare real estate market has experienced significant maturity within the past seven years and the divestment is set to capture the sector’s strong tailwinds, which are supported by sustainable market fundamentals such as limited supply, an ageing population and increasing operator demand.
The assets are to be sold individually in any combination, or in one-line through Mike Walsh, Peter Court and Frederic Le Fanue of Cushman & Wakefield and Simon Quinn, Elliott O’Shea, Nigel Freshwater and Mark Stafford of JLL.
According to Mike Walsh of Cushman & Wakefield, the portfolio is expected to be hotly contested given the appetite for the medical / healthcare asset class across Australia.
“This is set to be one of the most anticipated portfolio sales of 2022 – providing scale, geographical diversification and exposure to a highly sought-after asset class.
“The portfolio boasts a strong tenancy profile, underpinned by a mix of blue chip tenants and a highly desired range of uses including Private Hospitals, Medical Specialist Centres and Mental Health facilities to name a few.”
Simon Quinn of JLL stated “We have seen an influx of investor demand for healthcare assets, with capital being drawn to the sector’s defensive and non-cyclical income streams.
“We expect significant interest, locally and off-shore from a wide range of Institutional, Syndication & Private Capital groups” he said.
This national portfolio is for sale via EOI closing on Thursday 2 June 2022.
Related Articles
